KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Revenue (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Revenue for 4 consecutive years, with $55.4 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Revenue fell 16.52% year-over-year to $55.4 million, compared with a TTM value of $216.7 million through Dec 2023, down 54.64%, and an annual FY2024 reading of -$94000.0, down 1.08% over the prior year.
  • Revenue was $55.4 million for Q3 2023 at Ginkgo Bioworks Holdings, down from $80.6 million in the prior quarter.
  • Across five years, Revenue topped out at $168.4 million in Q1 2022 and bottomed at -$590000.0 in Q4 2020.
  • Average Revenue over 4 years is $78.5 million, with a median of $77.6 million recorded in 2021.
  • The sharpest move saw Revenue skyrocketed 25268.47% in 2021, then plummeted 52.08% in 2023.
  • Year by year, Revenue stood at -$590000.0 in 2020, then surged by 25268.47% to $148.5 million in 2021, then plummeted by 33.81% to $98.3 million in 2022, then crashed by 43.6% to $55.4 million in 2023.
  • Business Quant data shows Revenue for DNA at $55.4 million in Q3 2023, $80.6 million in Q2 2023, and $80.7 million in Q1 2023.